Altogether, this suggests that the history of the tumor is critically important for therapeutic decision-making, as the tumor composition prior to chemotherapy portends the changes that will occur in response to chemotherapy, which then informs prognosis and response for subsequent targeting of the PD1/PDL1 axis. The gene discussed is PDCD1; the disease is neoplasm.